跳至主要内容
临床试验/DRKS00032062
DRKS00032062
招募中
不适用

Disease progression in Patients with Parkinson’s disease uncontrolled on oral medication – a prospective, multicenter, observational study to assess health related quality of life over 24 months in Germany - PLUTO

euroTransData GmbH0 个研究点目标入组 258 人2023年6月12日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
G20
发起方
euroTransData GmbH
入组人数
258
状态
招募中
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年6月12日
结束日期
待定
最后更新
去年
研究类型
Observational
性别
All

研究者

发起方
euroTransData GmbH

入排标准

入选标准

  • male, female, or non\-binary
  • Patients with confirmed idiopathic Parkinson’s disease
  • Using oral levodopa treatment
  • Patients with Parkinson’s disease in MANAGE PD categories 2 and 3
  • Willingness to sign and date a Patient Authorization Form to use and disclose personal health information (or informed consent form if required)
  • Being able to speak and understand the language of the provided patient questionnaire

排除标准

  • Participation in a concurrent clinical study
  • Patients with Parkinson’s disease in MANAGE PD category 1
  • Significant uncertainty around the diagnosis of PD (i.e. symptoms present such as early falls or early autonomic disturbances or lack of levodopa responsiveness)
  • Current or past treatment with a device aided therapy (eg, LCIG, LECIG, CSAI, DBS) at baseline.

结局指标

主要结局

未指定

相似试验